ImmunityBio receives approval for ANKTIVA in Macau for bladder cancer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. GOOGL
5. APGE
6. MU
7. HOOD
8. DFTX
9. USO
10. MSFT

Go back to ImmunityBio receives approval for ANKTIVA in Macau for bladder cancer
(NASDAQ: IBRX) Delayed: 7.29 -0.07 (0.95%)
Previous Close $7.36    52 Week High $ 
Open $7.49    52 Week Low $ 
Day High $7.55    P/E N/A 
Day Low $7.17    EPS $ 
Volume 6,296,780